The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT)

A. P. Bode, W. J. Castellani, E. D. Hodges, S. Yelverton

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The effect of lysed platelets on the activated coagulation time (ACT) was studied in heparinized whole blood during titration with protamine. Frozen-thawed washed platelet suspension, or a chromatography fraction thereof, or autologous frozen-thawed platelet-rich plasma was added in various dilutions to freshly drawn blood anticoagulated with 3,000 USP units/l heparin. After a 10 min incubation, the amount of protamine needed to restore the ACT to baseline ('protamine titration dose') was determined. We found that the protamine titration dose decreased in proportion to the amount of lysed platelet material added; expressed as a percentage of the total number of platelets present, each unit increase in lysed platelets produced a 1.7% ± 0.8 (SD) reduction in the protamine dose needed to normalize the ACT. A heparin activity assay showed that this effect was not due to anti-heparin activity of lysed platelets such as platelet factor 4 (PF4). Our data indicate that the procoagulant activity of platelet membranes reduced the sensitivity of the ACT to heparin. These findings suggest that membranous platelet microparticles may cause an inaccurate calculation, based on the ACT, of a protamine dose to reverse heparin anticoagulation in cardiopulmonary bypass procedures.

Original languageEnglish (US)
Pages (from-to)213-217
Number of pages5
JournalThrombosis and Haemostasis
Volume66
Issue number2
StatePublished - Jan 1 1991

Fingerprint

Protamines
Heparin
Blood Platelets
Platelet Factor 4
Platelet-Rich Plasma
In Vitro Techniques
Cardiopulmonary Bypass
Platelet Count
Chromatography
Suspensions
Membranes

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this

Bode, A. P. ; Castellani, W. J. ; Hodges, E. D. ; Yelverton, S. / The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT). In: Thrombosis and Haemostasis. 1991 ; Vol. 66, No. 2. pp. 213-217.
@article{708d89ba15a047c0b54d1d3861844e49,
title = "The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT)",
abstract = "The effect of lysed platelets on the activated coagulation time (ACT) was studied in heparinized whole blood during titration with protamine. Frozen-thawed washed platelet suspension, or a chromatography fraction thereof, or autologous frozen-thawed platelet-rich plasma was added in various dilutions to freshly drawn blood anticoagulated with 3,000 USP units/l heparin. After a 10 min incubation, the amount of protamine needed to restore the ACT to baseline ('protamine titration dose') was determined. We found that the protamine titration dose decreased in proportion to the amount of lysed platelet material added; expressed as a percentage of the total number of platelets present, each unit increase in lysed platelets produced a 1.7{\%} ± 0.8 (SD) reduction in the protamine dose needed to normalize the ACT. A heparin activity assay showed that this effect was not due to anti-heparin activity of lysed platelets such as platelet factor 4 (PF4). Our data indicate that the procoagulant activity of platelet membranes reduced the sensitivity of the ACT to heparin. These findings suggest that membranous platelet microparticles may cause an inaccurate calculation, based on the ACT, of a protamine dose to reverse heparin anticoagulation in cardiopulmonary bypass procedures.",
author = "Bode, {A. P.} and Castellani, {W. J.} and Hodges, {E. D.} and S. Yelverton",
year = "1991",
month = "1",
day = "1",
language = "English (US)",
volume = "66",
pages = "213--217",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "2",

}

The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT). / Bode, A. P.; Castellani, W. J.; Hodges, E. D.; Yelverton, S.

In: Thrombosis and Haemostasis, Vol. 66, No. 2, 01.01.1991, p. 213-217.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The effect of lysed platelets on neutralization of heparin in vitro with protamine as measured by the activated coagulation time (ACT)

AU - Bode, A. P.

AU - Castellani, W. J.

AU - Hodges, E. D.

AU - Yelverton, S.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - The effect of lysed platelets on the activated coagulation time (ACT) was studied in heparinized whole blood during titration with protamine. Frozen-thawed washed platelet suspension, or a chromatography fraction thereof, or autologous frozen-thawed platelet-rich plasma was added in various dilutions to freshly drawn blood anticoagulated with 3,000 USP units/l heparin. After a 10 min incubation, the amount of protamine needed to restore the ACT to baseline ('protamine titration dose') was determined. We found that the protamine titration dose decreased in proportion to the amount of lysed platelet material added; expressed as a percentage of the total number of platelets present, each unit increase in lysed platelets produced a 1.7% ± 0.8 (SD) reduction in the protamine dose needed to normalize the ACT. A heparin activity assay showed that this effect was not due to anti-heparin activity of lysed platelets such as platelet factor 4 (PF4). Our data indicate that the procoagulant activity of platelet membranes reduced the sensitivity of the ACT to heparin. These findings suggest that membranous platelet microparticles may cause an inaccurate calculation, based on the ACT, of a protamine dose to reverse heparin anticoagulation in cardiopulmonary bypass procedures.

AB - The effect of lysed platelets on the activated coagulation time (ACT) was studied in heparinized whole blood during titration with protamine. Frozen-thawed washed platelet suspension, or a chromatography fraction thereof, or autologous frozen-thawed platelet-rich plasma was added in various dilutions to freshly drawn blood anticoagulated with 3,000 USP units/l heparin. After a 10 min incubation, the amount of protamine needed to restore the ACT to baseline ('protamine titration dose') was determined. We found that the protamine titration dose decreased in proportion to the amount of lysed platelet material added; expressed as a percentage of the total number of platelets present, each unit increase in lysed platelets produced a 1.7% ± 0.8 (SD) reduction in the protamine dose needed to normalize the ACT. A heparin activity assay showed that this effect was not due to anti-heparin activity of lysed platelets such as platelet factor 4 (PF4). Our data indicate that the procoagulant activity of platelet membranes reduced the sensitivity of the ACT to heparin. These findings suggest that membranous platelet microparticles may cause an inaccurate calculation, based on the ACT, of a protamine dose to reverse heparin anticoagulation in cardiopulmonary bypass procedures.

UR - http://www.scopus.com/inward/record.url?scp=0025740999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025740999&partnerID=8YFLogxK

M3 - Article

C2 - 1771614

AN - SCOPUS:0025740999

VL - 66

SP - 213

EP - 217

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 2

ER -